🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
31.37
-1.06 (-3.27%)
Nov 20, 2026, 4:00 PM EST - Market closed

Maze Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
1,7151,994---
Market Cap Growth
0.31%----
Enterprise Value
1,2981,634---
Last Close Price
31.3741.43---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
4.135.62---
P/TBV Ratio
4.005.62---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.140.070.144.940.32
Debt / EBITDA Ratio
--0.40--
Debt / FCF Ratio
--0.36--
Net Debt / Equity Ratio
-0.97-0.90-0.862.04-0.67
Net Debt / EBITDA Ratio
2.572.27-2.79-0.220.63
Net Debt / FCF Ratio
3.622.83-2.27-0.230.67
Asset Turnover
0.04-1.07--
Quick Ratio
13.8815.239.521.794.81
Current Ratio
14.1415.509.762.095.11
Return on Equity (ROE)
-37.49%-47.52%50.48%-180.12%-
Return on Assets (ROA)
-32.45%-41.13%2.18%-90.68%-76.65%
Return on Invested Capital (ROIC)
-65.87%-453.11%196.80%-307.50%-330.64%
Return on Capital Employed (ROCE)
-34.00%-38.20%26.20%-178.60%-86.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-8.50%-6.58%---
FCF Yield
-6.72%-5.66%---
Buyback Yield / Dilution
-88.16%-1474.04%-19.33%-13.82%-
SEC Filings: 10-K · 10-Q